Tiaochang Xiaoliu Decoction Granules prevent the recurrence of colorectal adenoma: a study protocol for a randomized controlled trial | Zendy

Cailing Zhong | Zendy; ShaoHua Wu | Zendy; Chunhui Chen | Zendy; Haocheng Huang | Zendy; Jiahao Mo | Zendy; Xiaobo Yang | Zendy; Chen Yan | Zendy; Beiping Zhang | Zendy

Open Access

Tiaochang Xiaoliu Decoction Granules prevent the recurrence of colorectal adenoma: a study protocol for a randomized controlled trial

Author(s) -

Cailing Zhong,

ShaoHua Wu,

Chunhui Chen,

Haocheng Huang,

Jiahao Mo,

Xiaobo Yang,

Chen Yan,

Beiping Zhang

Publication year - 2021

Publication title -

annals of palliative medicine

Language(s) - English

Resource type - Journals

eISSN - 2224-5839

pISSN - 2224-5820

DOI - 10.21037/apm-21-650

Subject(s) - medicine , colonoscopy , polypectomy , decoction , adenoma , colorectal cancer , randomized controlled trial , colorectal adenoma , incidence (geometry) , clinical trial , gastroenterology , cancer , physics , optics

With the changes in lifestyle and diet, the incidence and mortality of colorectal cancer (CRC) is increasing in China. CRC mainly develops from colorectal adenomas (CRAs). There is a lack of chemopreventative drugs with definite efficacy for CRAs. Tiaochang Xiaoliu Decoction (TXD) was developed by Professor Yunjian Luo and has been used clinically over the last ten years for the prevention of CRA recurrence. To facilitate its clinical use, TXD was further standardized and produced as "Tiaochang Xiaoliu Decoction Granules (TXDG)". A study was designed to investigate the preventive effects of TXDG on the recurrence of CRA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research